Tag: Cancer: Lymphoma
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk
Relationship Explored Between Physical Activity and Lymphoma
Dose-response analysis showed protective effect with 1 percent risk reduction per three MET hours/week
Most Women Unaware of Breast Implant-Related Lymphoma
Even among women with breast implants, just over half have heard of BIA-ALCL
Incidence of VTE, Major Bleeding High in Primary CNS Lymphoma
VTE risk up with chemotherapy, radiation therapy; major bleeding risk up with PE, proximal DVT
Bayer to Pay $10 Billion to Settle Roundup Lawsuits
Amount includes $1.25 billion for potential future claims from people who used Roundup
Rituximab + Chemo Ups Survival in Pediatric B-Cell Non-Hodgkin Lymphoma
Event-free survival significantly longer for children, teens with high-grade, high-risk disease
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients
Whole-Body DW MRI Can Help Assess Pediatric Tumor Response
Good agreement for treatment response assessments with DW MRI, FDG PET seen in children, young adults
Low Muscle Mass, Density Linked to Shorter Survival in Lymphoma
13 percent of DLBCL patients had LMM, LMD, which was associated with shorter OS and PFS
